Laura-Elena Cucu

Dr. Laura-Elena Cucu

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 August 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
CGCristina Grosu
Cristina Grosu
EIEmilian Bogdan Ignat
Emilian Bogdan Ignat
DADaniel Alexa
Daniel Alexa
Ciubotaru Alin FlorentinCiubotaru Alin Florentin
Ciubotaru Alin Florentin
MLMaria Magdalena Leon
Maria Magdalena Leon
DTDAN TROFIN
DAN TROFIN
Multiple sclerosis (MS) is a chronic, immune-mediated neurological disorder with increasing global prevalence. Emerging evidence underscores the role of lifestyle interventions (particularly diet and physical activity) in modulating disease progression and improving quality of life. This narrative review synthesizes current scientific literature on the effects of dietary interventions, including the Mediterranean, ketogenic, Swank, Wahls, gluten-free, and fasting-based diets, alongside various physical activity regimens. The Mediterranean and ketogenic diets show promise in reducing inflammation, enhancing neuroprotection, and improving metabolic health. Similarly, structured physical activity (including aerobic, resistance, sensorimotor, and mind–body exercises) demonstrates benefits in mobility, fatigue, and mental well-being. The review highlights the need for personalized, sustainable approaches that integrate nutritional and exercise-based strategies for optimal MS management in the long term.

20 July 2023 in Psychiatry Research: Neuroimaging
Verified
Journal Article
Closed access
LCLaura-Elena Cucu
Laura-Elena Cucu
EMEmanuel Moisa
Emanuel Moisa
ASAlexandra Sevastre-Berghian
Alexandra Sevastre-Berghian
RMRemus Moldovan
Remus Moldovan
RDRoxana Decea
Roxana Decea
BSBogdan Stancu
Bogdan Stancu

24 May 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
LCLaura-Elena Cucu
Laura-Elena Cucu
Gabriela PopescuGabriela Popescu
Gabriela Popescu
AMAlexandra Mastaleru
Alexandra Mastaleru
EIEmilian Bogdan Ignat
Emilian Bogdan Ignat
CGCristina Grosu
Cristina Grosu
MLMaria Magdalena Leon
Maria Magdalena Leon
Common peroneal nerve neuropathy at the fibular head secondary to weight loss is known as slimmer’s paralysis. Although this pathology has long been documented in medical literature, it has gained more clinical significance in recent years due to the global rise in obesity and the increasing pursuit of rapid weight loss methods. While case reports exist in the current literature, there are limited data regarding its optimal management. This study summarizes all reported cases of common peroneal nerve paralysis after weight loss and reports one additional case, exploring disease mechanisms as well as diagnostic and therapeutic strategies. A literature review was conducted on the platforms PubMed, Google Scholar, and EMBASE. A total of 380 patients were included. Laterality of neuropathy was specified in 297 (78.16%) patients: 285 (95.96%) with unilateral neuropathy and 12 (4.04%) with bilateral neuropathy. A total of 19 (5.00%) patients had sudden onset, and in 145 (38.16%) of cases, the Tinel’s sign was positive. Additionally, 373 (98.16%) patients underwent nerve conduction studies, demonstrating the fibular head as the site of injury. MRI or ultrasound imaging of the knee is indicated to exclude compressive etiology. A total of 302 (79.47%) cases were treated surgically and 42 (11.58%) conservatively, predominantly with favorable outcomes, regardless of the therapeutic approach chosen. Although the predominance of surgically treated cases in the literature limits definitive treatment recommendations, conservative management appears appropriate when an extended recovery time is acceptable, while surgical decompression is indicated in cases showing no improvement after 3 months.

24 December 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
Ciubotaru Alin FlorentinCiubotaru Alin Florentin
Ciubotaru Alin Florentin
RCRoxana Covali
Roxana Covali
CGCristina Grosu
Cristina Grosu
DADaniel Alexa
Daniel Alexa
LRlaura riscanu
laura riscanu
EIEmilian Bogdan Ignat
Emilian Bogdan Ignat
Background: The clinical–radiological paradox in multiple sclerosis (MS) underscores the need for biomarkers that better reflect neurodegenerative pathology. Serum neurofilament light chain (sNfL) is a dynamic marker of neuroaxonal injury, while brain volumetry provides structural assessment of disease impact. However, the precise link between sNfL and regional atrophy patterns, as well as their combined utility for patient stratification and prediction, remains underexplored. Objective: This study aimed to establish a multimodal biomarker framework by integrating sNfL with comprehensive volumetric MRI to define neurodegenerative endophenotypes and predict neuroaxonal injury using Bayesian inference and machine learning. Methods: In a cohort of 57 MS patients, sNfL levels were measured using single-molecule array (Simoa) technology. Brain volumes for 42 regions were quantified via automated deep learning segmentation (mdbrain software). We employed (1) Bayesian correlation to quantify evidence for sNfL–volumetric associations; (2) mediation analysis to test whether grey matter atrophy mediates the EDSS–sNfL (Expanded Disability Status Scale) relationship; (3) unsupervised K-means clustering to identify patient subtypes based on combined sNfL–volumetric profiles; and (4) supervised machine learning (Elastic Net and Random Forest regression) to predict sNfL from volumetric features. Results: Bayesian analysis revealed strong evidence linking sNfL to total grey matter volume (r = −0.449, BF10 = 0.022) and lateral ventricular volume (r = 0.349, BF10 = 0.285). Mediation confirmed that grey matter atrophy significantly mediates the relationship between EDSS and sNfL (indirect effect = 0.45, 95% CI [0.20, 0.75]). Unsupervised clustering identified three distinct endophenotypes: “High Neurodegeneration” (elevated sNfL, severe atrophy, high disability), “Moderate Injury,” and “Benign Volumetry” (low sNfL, preserved volumes, mild disability). Supervised models predicted sNfL with high accuracy (R2 = 0.65), identifying total grey matter volume, ventricular volume, and age as top predictors. Conclusions: This integrative multi-method analysis demonstrates that sNfL is robustly associated with global grey matter and ventricular volumes, and that these measures define clinically meaningful neurodegenerative subtypes in MS. Machine learning confirms that a concise set of volumetric features can effectively predict neuroaxonal injury. These findings advance a pathobiology-driven subtyping framework and provide a validated model for using routine MRI volumetry to assess neuroaxonal health, with implications for prognosis and personalised therapeutic strategies.

21 April 2026 in Life
Verified
Journal Article
Open access
PDF file
LCLaura-Elena Cucu
Laura-Elena Cucu
LBLaura Cristina Baciu
Laura Cristina Baciu
CGCristina Grosu
Cristina Grosu
EIEmilian Bogdan Ignat
Emilian Bogdan Ignat
CCCARMEN MARINELA CUMPAT
CARMEN MARINELA CUMPAT
MLMaria Magdalena Leon
Maria Magdalena Leon
Cognitive rehabilitation represents a cornerstone of disease management in multiple sclerosis (MS), targeting the progressive cognitive decline that affects a significant proportion of patients. Despite growing evidence supporting its clinical utility, rehabilitation outcomes remain variable, and identifying modifiable factors that limit its efficacy has become a research priority. Sleep disorders are common in MS and have been increasingly linked to cognitive impairment, yet evidence based on objective polysomnographic assessment remains limited, and the specific parameters that influence cognitive function are poorly understood. This review synthesizes evidence from polysomnographic studies examining how sleep disturbances influence cognitive performance in MS patients. Following a systematic search of PubMed, EMBASE, and the Cochrane Library, 488 patients were included. Sleep fragmentation, reduced sleep efficiency, and oxygen desaturation indices were associated with impairments in attention, information processing speed, and verbal memory, with nocturnal hypoxia emerging as a potentially important mechanism of cognitive impairment. These findings suggest that identifying and treating sleep disorders may be essential for optimizing cognitive rehabilitation outcomes in MS. Further longitudinal studies are needed to determine whether addressing sleep pathology can enhance rehabilitation efficacy and preserve cognitive function over time.

30 September 2025 in Balneo and PRM Research Journal
Verified
Journal Article
Closed access
RCRoxana Covali
Roxana Covali
CGCristina Grosu
Cristina Grosu
DADaniel Alexa
Daniel Alexa
APAndreea- Ioana Pruteanu
Andreea- Ioana Pruteanu
ACAndrei Ionuț Cucu
Andrei Ionuț Cucu
CFCristiana Filip
Cristiana Filip
Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, with an increasing incidence despite advances in diagnosis and treatment. Coronary heart disease, particularly acute myocardial infarction, accounts for a significant proportion of cardiovascular deaths. Metabolic imbalances, gut microbiota dysbiosis, and systemic conditions such as obesity and metabolic syndrome contribute to chronic inflammation, endothelial dysfunction, and atherosclerosis progression. This study synthesized evidence from recent clinical and experimental research addressing three main areas: (1) the interplay between gut microbiota dysbiosis, metabolic alterations, and myocardial infarction risk, with emphasis on therapeutic strategies for modulating gut microbiota; (2) the impact of motor neurological disabilities on metabolic regulation and cardiovascular outcomes; and (3) the influence of epigenetic modifications on metabolic pathways relevant to coronary heart disease. Data from proteomic and metabolomic studies were integrated to provide a systems-level perspective. Analysis revealed that gut microbiota dysbiosis promotes systemic inflammation and endothelial dysfunction, amplifying atherosclerotic processes and myocardial infarction risk. Motor neurological impairments were associated with unfavorable metabolic changes that further increase cardiovascular vulnerability. Epigenetic alterations were shown to regulate genes involved in lipid and carbohydrate metabolism, thereby influencing coronary heart disease progression. Proteomics and metabolomics approaches provided comprehensive insights into molecular signatures linking these mechanisms. The integration of microbiome, metabolic, and epigenetic perspectives highlights a complex interplay underlying myocardial infarction risk. Understanding these interactions may enable the development of personalized prevention and treatment strategies, including microbiota-targeted therapies, metabolic modulation, and epigenetic interventions, ultimately contributing to improved cardiovascular outcomes.